{"id":"https://openalex.org/W2272409540","doi":null,"title":"Third-generation antidepressants: do they offer advantages over the SSRIs? -editorial-","display_name":"Third-generation antidepressants: do they offer advantages over the SSRIs? -editorial-","publication_year":2002,"publication_date":"2002-01-01","ids":{"openalex":"https://openalex.org/W2272409540","mag":"2272409540"},"language":"en","primary_location":{"id":"mag:2272409540","doi":null,"is_oa":false,"landing_page_url":"http://search.informit.com.au/fullText;dn=526071345336915;res=IELHEA","pdf_url":null,"source":{"id":"https://openalex.org/S45078479","display_name":"Current therapeutics","issn_l":"0311-905X","issn":["0311-905X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Current therapeutics","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050193515","display_name":"James S. Olver","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"JS Olver","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020676517","display_name":"Trevor Ronald Norman","orcid":"https://orcid.org/0000-0003-2903-7096","observed_orcids":["https://orcid.org/0000-0003-2903-7096"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Trevor R. Norman","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2903-7096","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110148926","display_name":"G D Burrows","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G D Burrows","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1757,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.54505266,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"43","issue":"7","first_page":"7","last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13118","display_name":"Psychological Treatments and Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.9890000224113464},{"id":"https://openalex.org/keywords/venlafaxine","display_name":"venlafaxine","score":0.9810000061988831},{"id":"https://openalex.org/keywords/reboxetine","display_name":"reboxetine","score":1.0},{"id":"https://openalex.org/keywords/nefazodone","display_name":"nefazodone","score":1.0},{"id":"https://openalex.org/keywords/mirtazapine","display_name":"mirtazapine","score":1.0},{"id":"https://openalex.org/keywords/antidepressant-efficacy","display_name":"antidepressant efficacy","score":0.9800000190734863},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.9900000095367432},{"id":"https://openalex.org/keywords/onset-of-action","display_name":"onset of action","score":0.8029999732971191},{"id":"https://openalex.org/keywords/antidepressant-safety","display_name":"antidepressant safety","score":0.8080000281333923}],"concepts":[{"id":"https://openalex.org/C2779419675","wikidata":"https://www.wikidata.org/wiki/Q416632","display_name":"Nefazodone","level":5,"score":0.9088285565376282},{"id":"https://openalex.org/C2780467756","wikidata":"https://www.wikidata.org/wiki/Q418970","display_name":"Reboxetine","level":5,"score":0.9050536155700684},{"id":"https://openalex.org/C2776466888","wikidata":"https://www.wikidata.org/wiki/Q898407","display_name":"Venlafaxine","level":4,"score":0.8983906507492065},{"id":"https://openalex.org/C2781068410","wikidata":"https://www.wikidata.org/wiki/Q421930","display_name":"Mirtazapine","level":4,"score":0.8768662214279175},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.7231313586235046},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.7103913426399231},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6824241280555725},{"id":"https://openalex.org/C3018907156","wikidata":"https://www.wikidata.org/wiki/Q7785058","display_name":"Third generation","level":2,"score":0.6160436272621155},{"id":"https://openalex.org/C2779908668","wikidata":"https://www.wikidata.org/wiki/Q834280","display_name":"Bupropion","level":3,"score":0.5979201793670654},{"id":"https://openalex.org/C2780092697","wikidata":"https://www.wikidata.org/wiki/Q7455053","display_name":"Serotonin reuptake inhibitor","level":4,"score":0.5570870041847229},{"id":"https://openalex.org/C2780831388","wikidata":"https://www.wikidata.org/wiki/Q416701","display_name":"Mianserin","level":4,"score":0.5415970683097839},{"id":"https://openalex.org/C2910584757","wikidata":"https://www.wikidata.org/wiki/Q334477","display_name":"Serotonin Uptake Inhibitors","level":5,"score":0.5344860553741455},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.5254570245742798},{"id":"https://openalex.org/C2777490545","wikidata":"https://www.wikidata.org/wiki/Q409672","display_name":"Citalopram","level":4,"score":0.49102282524108887},{"id":"https://openalex.org/C2909532165","wikidata":"https://www.wikidata.org/wiki/Q898407","display_name":"Venlafaxine Hydrochloride","level":5,"score":0.48928210139274597},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.45448634028434753},{"id":"https://openalex.org/C2780199185","wikidata":"https://www.wikidata.org/wiki/Q421058","display_name":"Milnacipran","level":4,"score":0.42222708463668823},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.35134780406951904},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.3240409195423126},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20360437035560608},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.09436887502670288},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.06503939628601074},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C76155785","wikidata":"https://www.wikidata.org/wiki/Q418","display_name":"Telecommunications","level":1,"score":0.0},{"id":"https://openalex.org/C2777843972","wikidata":"https://www.wikidata.org/wiki/Q2462253","display_name":"Smoking cessation","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2272409540","doi":null,"is_oa":false,"landing_page_url":"http://search.informit.com.au/fullText;dn=526071345336915;res=IELHEA","pdf_url":null,"source":{"id":"https://openalex.org/S45078479","display_name":"Current therapeutics","issn_l":"0311-905X","issn":["0311-905X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Current therapeutics","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2087328751","https://openalex.org/W2416306776","https://openalex.org/W2125752152","https://openalex.org/W4288738662","https://openalex.org/W2595030517","https://openalex.org/W3042087851","https://openalex.org/W2063670236","https://openalex.org/W308740067","https://openalex.org/W2074016011","https://openalex.org/W1486881060"],"abstract_inverted_index":{"Third-generation":[0],"antidepressants":[1,36,55],"are":[2,56],"a":[3],"group":[4],"of":[5,8,42,49,57],"antidepressant":[6],"agents":[7,19,39],"variable":[9],"action,":[10],"not":[11],"confined":[12],"to":[13,29,60],"serotonin":[14,62],"reuptake":[15,63],"inhibition.":[16],"These":[18],"include":[20],"venlafaxine,":[21],"reboxetine,":[22],"nefazodone":[23],"and":[24,37,47,65],"mirtazapine.":[25],"There":[27],"appear":[28],"be":[30],"no":[31],"convincing":[32],"differences":[33],"between":[34],"third-generation":[35],"comparator":[38],"in":[40,68],"terms":[41],"overall":[43],"efficacy,":[44],"relapse":[45],"prevention":[46],"speed":[48],"onset.":[50],"Third-":[52],"generation":[54],"equivalent":[58],"safety":[59,69],"selective":[61],"inhibitors":[64],"offer":[66],"improvements":[67],"over":[70],"first-generation.":[71],"(author":[73],"abstract)":[74]},"counts_by_year":[{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}